Skip to main content
Log in

Prognostic usefulness of planar 123I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HF

  • Original Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

Background

To evaluate whether planar 123I-MIBG myocardial scintigraphy predicts risk of death in heart failure (HF) patients up to 5 years after imaging.

Methods and Results

Subjects from ADMIRE-HF were followed for approximately 5 years after imaging (964 subjects, median follow-up 62.7 months). Subjects were stratified according to the heart/mediastinum (H/M) ratio (< 1.60 vs ≥ 1.60) on planar 123I-MIBG scintigraphic images obtained at baseline in ADMIRE-HF. Cox proportional hazards models and Kaplan-Meier analyses were used to evaluate time to death, cardiac death, or arrhythmic events for subjects stratified by H/M ratio, baseline left ventricular ejection fraction (LVEF: < 25% and 25 to ≤ 35%), and by H/M strata within LVEF strata. All-cause mortality was 38.4% vs 20.9% and cardiac mortality was 16.8% vs 4.5%, in subjects with H/M < 1.60 vs ≥ 1.60, respectively (P < 0.05 for both comparisons). Subjects with preserved sympathetic innervation of the myocardium (H/M ≥ 1.60) were at significantly lower risk of all-cause and cardiac death, arrhythmic events, sudden cardiac death, or potentially life-threatening arrhythmias. Within LVEF strata, a trend toward a higher mortality for subjects with H/M < 1.60 was observed reaching significance for LVEF 25 to ≤ 35% only.

Conclusions

During a median follow-up of 62.7 months, patients with H/M ≥ 1.60 were at significantly lower risk of death and arrhythmic events independently of LVEF values.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Abbreviations

CHF:

Chronic heart failure

HF:

Heart failure

H/M:

Heart/mediastinum

HR:

Hazard ratio

ICD:

Implantable cardioverter defibrillator

LVAD:

Left ventricular assist device

LVEF:

Left ventricular ejection fraction

MIBG:

Metaiodobenzylguanidine

NYHA:

New York Heart Association

References

  1. Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, ADMIRE-HF Investigators, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective AdreView myocardial imaging for risk evaluation in heart failure (ADMIRE-HF) study. J Am Coll Cardiol 2010;55:2212-21. https://doi.org/10.1016/j.jacc.2010.01.014.

    Article  PubMed  Google Scholar 

  2. Narula J, Gerson M, Thomas GS, Cerqueira MD, Jacobson AF. 123I-MIBG imaging for prediction of mortality and potentially fatal events in heart failure: The ADMIRE-HFX study. J Nucl Med 2015;56:1011-8. https://doi.org/10.2967/jnumed.115.156406.

    Article  PubMed  Google Scholar 

  3. Jacobson AF, Lombard J, Banerjee G, Camici PG. 123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: Design of two prospective multicenter international trials. J Nucl Cardiol 2009;16:113-21. https://doi.org/10.1007/s12350-008-9008-2.

    Article  PubMed  Google Scholar 

  4. Ketchum ES, Jacobson AF, Caldwell JH, Senior R, Cerqueira MD, Thomas GS, et al. Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol 2012;19:1007-16. https://doi.org/10.1007/s12350-012-9603-0.

    Article  PubMed  Google Scholar 

  5. Merlet P, Benvenuti C, Moyse D, Pouillart F, Dubois-Randé JL, Duval AM, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999;40:917-23.

    CAS  PubMed  Google Scholar 

  6. Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: A systematic review. Eur Heart J 2008;29:1147-59. https://doi.org/10.1093/eurheartj/ehn113.

    Article  PubMed  Google Scholar 

  7. Cohen-Solal A, Esanu Y, Logeart D, Pessione F, Dubois C, Dreyfus G, et al. Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: Relationship with peak oxygen uptake and prognosis. J Am Coll Cardiol 1999;33:759-66.

    Article  CAS  Google Scholar 

  8. Wakabayashi T, Nakata T, Hashimoto A, Yuda S, Tsuchihashi K, Travin MI, et al. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death. J Nucl Med 2001;42:1757-67.

    CAS  PubMed  Google Scholar 

  9. Nakata T, Miyamoto K, Doi A, Sasao H, Wakabayashi T, Kobayashi H, et al. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts. J Nucl Cardiol 1998;5:579-90.

    Article  CAS  Google Scholar 

  10. Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, et al. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging 2014;41:1673-82. https://doi.org/10.1007/s00259-014-2759-x.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Køber L, Thune JJ, Nielsen JC, Haarbo J, Videbæk L, Korup E, DANISH Investigators, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Engl J Med 2016;375:1221-30. https://doi.org/10.1056/NEJMoa1608029.

    Article  PubMed  Google Scholar 

  12. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, American College of Cardiology Foundation; American Heart Association Task Force on Practice Guidelines, et al. 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;2013:e147-239. https://doi.org/10.1016/j.jacc.2013.05.019.

    Article  Google Scholar 

  13. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, ESC Scientific Document Group, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016;2016:2129-200. https://doi.org/10.1093/eurheartj/ehw128.

    Article  Google Scholar 

  14. Barra S, Providencia R, Agarwal S. Do we need further clinical-effectiveness estimates to support the use of primary prevention implantable cardioverter-defibrillators in New York Heart Association class III patients? Int J Cardiol 2016;203:184-6. https://doi.org/10.1016/j.ijcard.2015.10.080.

    Article  PubMed  Google Scholar 

  15. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res 2004;95:754-63.

    Article  CAS  Google Scholar 

  16. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.

    Article  CAS  Google Scholar 

  17. O’Day K, Levy WC, Johnson M, Jacobson AF. Cost-effectiveness analysis of iodine-123 meta-iodobenzylguanidine imaging for screening heart failure patients eligible for an implantable cardioverter defibrillator in the USA. Appl Health Econ Health Policy 2016;14:361-73. https://doi.org/10.1007/s40258-016-0234-5.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Medical writing support was provided by Winfield Consulting.

Disclosures

D Agostini, K Ananthasubramaniam, H Chandna, L Friberg, A Hudnut, M Koren, MI Miyamoto, R Senior, M Shah, MI Travin, J vom Dahl, and WC Levy declare no conflict of interest regarding this study. K Chen was an employee of GE Healthcare.

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Denis Agostini MD, PhD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarizes the contents of the paper and is free for re-use at meetings and presentations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PPTX 182 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agostini, D., Ananthasubramaniam, K., Chandna, H. et al. Prognostic usefulness of planar 123I-MIBG scintigraphic images of myocardial sympathetic innervation in congestive heart failure: Follow-Up data from ADMIRE-HF. J. Nucl. Cardiol. 28, 1490–1503 (2021). https://doi.org/10.1007/s12350-019-01859-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-019-01859-w

Keywords

Navigation